Yukihiro Ohno

J-GLOBAL         Last updated: Jul 13, 2019 at 12:17
 
Avatar
Name
Yukihiro Ohno
Affiliation
Osaka University of Pharmaceutical Sciences
Section
Faculty of Pharmaceutical Sciences

Research Areas

 
 

Academic & Professional Experience

 
Apr 2011
 - 
Today
Professor, Laboratory of Pharmacology, Osaka University of Pharmaceutical Sciences
 
Apr 2007
 - 
Mar 2011
Associate Professor, Laboraotry of Pharmacology, Osaka University of Pharmaceutical Scicences
 
Jan 2006
 - 
Mar 2007
Assistant Professor, Laboratory of Molecular and Cellular Pharmacology, Osaka University, Graduate School of Medicine
 

Published Papers

 
Serikawa T, Kunisawa N, Shimizu S, Kato M, Alves Iha H, Kinboshi M, Nishikawa H, Shirakawa Y, Voigt B, Nakanishi S, Kuramoto T, Kaneko T, Yamamoto T, Mashimo T, Sasa M, Ohno Y
Behavioural brain research   111922   Apr 2019   [Refereed]
Iha HA, Kunisawa N, Shimizu S, Onishi M, Nomura Y, Matsubara N, Iwai C, Ogawa M, Hashimura M, Sato K, Kato M, Ohno Y
Neurotoxicity research      Feb 2019   [Refereed]
Nishitani A, Kunisawa N, Sugimura T, Sato K, Yoshida Y, Suzuki T, Sakuma T, Yamamoto T, Asano M, Saito Y, Ohno Y, Kuramoto T
Brain research   1706 209-217   Mar 2019   [Refereed]
Kinboshi M, Shimizu S, Mashimo T, Serikawa T, Ito H, Ikeda A, Takahashi R, Ohno Y
International journal of molecular sciences   20(5)    Feb 2019   [Refereed]
Ohno Y, Kinboshi M, Shimizu S
International journal of molecular sciences   19(11)    Oct 2018   [Refereed]

Misc

 
Function of synaptic vesicle protein 2A (SV2A) as a novel therapeutic target for epilepsy
Kentaro Tokudome, Saki Shimizu, Tadao Serikawa, Yukihiro Ohno
Folia Pharmacologica Japonica   152 275-280   Dec 2018

Books etc

 
Serotonin: The mediator that spans evolution
Yukihiro Ohno (Part:Contributor, Serotonin receptors as the therapeutic target for central nervous system disorders.)
Elsevier Science   Jan 2019   
In Vivo Neuropharmacology and Neurophysiology
H.A. Iha, N. Kunisawa, K. Tokudome, T. Mukai, M. Kinboshi, S. Shimizu, Y. Ohno (Part:Contributor, Immunohistochemical analysis of Fos protein expression for exploring brain regions related to central nervous system disorders and drug actions)
Springer   Oct 2017   
Antipsychotic Drugs: Pharmacology, Side Effects and Abuse Prevention
Y. Ohno, S. Shimizu, J. Imaki, A. Masui, A. Tatara (Part:Contributor, Management of antipsychotic-induced extrapyramidal motor disorders: Regulatory roles of the serotonergic nervous system)
Nova Science Publishers   2013   
Emerging Drugs and Targets for Parkinson’s Disease
Saki Shimizu, Yukihiro Ohno (Part:Contributor, 5-HT1A receptors as a therapeutic target for Parkinson’s disease)
RSC Publishing   2013   
Schizophrenia Research: Recent Advances
Y. Ohno, A. Tatara, S. Shimizu, M. Sasa (Part:Contributor, Management of cognitive impairments in schizophrenia: The therapeutic role of 5-HT receptors.)
Nova Science Publishers   2012   

Conference Activities & Talks

 
てんかんと精神機能調節におけるSV2Aの役割 [Invited]
Yukihiro Ohno
The 3rd Kinki Epilepsy Summit   11 May 2019   
Mechanisms underlying the pathogenesis and treatment of neurological disorders: Extrapyramidal motor disorders [Invited]
Yukihiro Ohno, Saki Shimizu
14 Mar 2019   
Role of astrocytic Kir4.1 channels in modulating epileptogenesis. [Invited]
Yukihiro Ohno
7 Sep 2017   
Role of synaptic vesicle glycoprotein 2A (SV2A) in modulating epileptogenesis. [Invited]
Yukihiro Ohno
5th Asian College of Neuropsychopharmacology (Symposium)   27 Apr 2017   
Function of Synaptic Vesicle Glycoprotein 2A as a Novel Therapeutic Target for Epilepsy. [Invited]
Yukihiro Ohno
15 Mar 2017   

Social Contribution

 
Associate Editor: Journal Pharmacological Sciences
[Editor]
Editor: Frontiers in Pharmacology
[Editor]
Editor: Frontiers in Neuroscience
[Editor]
Editor: Frontiers in Neurology
[Editor]
Associate Editor: Biological Pharmaceutical Bulletin
[Editor]
Guest Editor: International Journal of Molecular Sciences, Special Issue "Astrocytes: Emerging Roles in the Pathogenesis and Treatment of CNS disorders"
[Editor]
Editor in Chief: Therapeutic Targets for Neurological Diseases
[Chief Editor]  Apr 2014 - Jun 2017
Editorial Board Member: International Journal of Molecular Sciences
[Editor]
Editorial Board Member: CNS & Neurological Disorders-Drug Targets
[Editor]